Clinical Trial Update: Study to Compare the Anti-tetanus Neutralizing Antibody Titers and Safety of TNM002 Injection With Human Tetanus Immunoglobulin or Placebo in Adult Volunteers [Phase 2]

View source ↗

Summary

Phase 2 trial comparing TNM002 anti-tetanus neutralizing antibody with human tetanus immunoglobulin or placebo in adults; the study evaluates neutralizing antib…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tetanus

Drugs mentioned

• Human tetanus immunoglobulin (tetanus immunoglobulin)
• TNM002

Snippet

Sponsor: Zhuhai Trinomab Pharmaceutical Co., Ltd. | Conditions: Tetanus | Phase 2 | Status: COMPLETED | Results posted: 2025-09-16